{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T03:48:28Z","timestamp":1760586508799},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T00:00:00Z","timestamp":1266019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s10620-010-1140-6","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T18:04:18Z","timestamp":1265997858000},"page":"877-879","source":"Crossref","is-referenced-by-count":7,"title":["Rifaximin and Crohn\u2019s Disease: A New Solution to an Old Problem?"],"prefix":"10.1007","volume":"55","author":[{"given":"A. S.","family":"Day","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. B.","family":"Gearry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,13]]},"reference":[{"key":"1140_CR1","doi-asserted-by":"crossref","unstructured":"Shafran I, Burgunder P. Adjunctive antibiotic therapy with rifaximin may help reduce Crohn\u2019s disease activity. Dig Dis Sci. 2010. doi: 10.1007\/s10620-009-1111-y","DOI":"10.1007\/s10620-009-1111-y"},{"key":"1140_CR2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.bpg.2004.01.002","volume":"18","author":"AM Griffiths","year":"2004","unstructured":"Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004;18:509\u2013523.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1140_CR3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00054725-199709000-00008","volume":"3","author":"RB Sartor","year":"1997","unstructured":"Sartor RB. Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis. 1997;3:230\u2013235.","journal-title":"Inflamm Bowel Dis"},{"key":"1140_CR4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","volume":"115","author":"C Fiocchi","year":"1998","unstructured":"Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182\u2013205.","journal-title":"Gastroenterology"},{"key":"1140_CR5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1523-5378.2008.00607.x","volume":"13","author":"SM Man","year":"2008","unstructured":"Man SM, Zhang L, Day AS, Leach S, Mitchell HM. Detection of enterohepatic and gastric Helicobacter species in fecal specimens of children with Crohn\u2019s Disease. Helicobacter. 2008;13:234\u2013238.","journal-title":"Helicobacter"},{"key":"1140_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/JCM.01949-08","volume":"47","author":"L Zhang","year":"2009","unstructured":"Zhang L, Man SM, Day AS, et al. Non-jejuni Campylobacter species are associated with Crohn\u2019s disease in children. J Clin Micro. 2009;47:453\u2013455.","journal-title":"J Clin Micro"},{"key":"1140_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ibd.20330","volume":"14","author":"A Swidsinski","year":"2008","unstructured":"Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn\u2019s disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis. 2008;14:147\u2013161.","journal-title":"Inflamm Bowel Dis"},{"key":"1140_CR8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1128\/IAI.69.4.2277-2285.2001","volume":"69","author":"HC Rath","year":"2001","unstructured":"Rath HC, Schultz M, Freitag R, et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun. 2001;69:2277\u20132285.","journal-title":"Infect Immun"},{"key":"1140_CR9","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0016-5085(00)70362-3","volume":"118","author":"KL Madsen","year":"2000","unstructured":"Madsen KL, Doyle JS, Tavernini MM, et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology. 2000;118:1094\u20131105.","journal-title":"Gastroenterology"},{"key":"1140_CR10","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0016-5085(99)70013-2","volume":"116","author":"KL Madsen","year":"1999","unstructured":"Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 1999;116:1107\u20131114.","journal-title":"Gastroenterology"},{"key":"1140_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","volume":"114","author":"GR D\u2019Haens","year":"1998","unstructured":"D\u2019Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262\u2013267.","journal-title":"Gastroenterology"},{"key":"1140_CR12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2036.2008.03796.x","volume":"28","author":"ST Leach","year":"2008","unstructured":"Leach ST, Mitchell HM, Eng WR, Zhang L, Day AS. Sustained modulation of intestinal microflora by exclusive enteral nutrition used to treat children with Crohn\u2019s disease. Aliment Pharmacol Ther. 2008;28:724\u2013733.","journal-title":"Aliment Pharmacol Ther"},{"key":"1140_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MOG.0b013e32832b20bf","volume":"25","author":"C Prantera","year":"2009","unstructured":"Prantera C, Scribano ML. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Curr Opin Gastroenterol. 2009;25:329\u2013333.","journal-title":"Curr Opin Gastroenterol"},{"key":"1140_CR14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1185\/030079905X53252","volume":"1","author":"I Shafran","year":"2005","unstructured":"Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn\u2019s disease. Curr Med Res Opin. 2005;1:1165\u20131169.","journal-title":"Curr Med Res Opin"},{"key":"1140_CR15","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2036.2006.02879.x","volume":"23","author":"C Prantera","year":"2006","unstructured":"Prantera C, Lochs H, Campieri M, et al. Antibiotic treatment of Crohn\u2019s disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther. 2006;23:1117\u20131125.","journal-title":"Aliment Pharmacol Ther"},{"key":"1140_CR16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0b013e3181a0d269","volume":"49","author":"P Muniyappa","year":"2009","unstructured":"Muniyappa P, Gulati R, Mohr F, Hupertz V. Use and safety of rifaximin in children with inflammatory bowel disease. Pediatr Gastroenterol Nutr. 2009;49:400\u2013404.","journal-title":"Pediatr Gastroenterol Nutr"},{"key":"1140_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1572-0241.2007.01562_13.x","volume":"103","author":"DB Doman","year":"2008","unstructured":"Doman DB, Goldberg HJ, Golding MI. \u201cEcologic niche\u201d therapy for Crohn\u2019s disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy. Am J Gastroenterol. 2008;103:251\u2013252.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1140-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1140-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1140-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:42:56Z","timestamp":1559245376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1140-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,13]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1140"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1140-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,13]]}}}